Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2026-09-08 08:31:48 ET · period of report 2026-08-27 · accession 0001971798-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-08 08:31 | 2026-08-27 | NMTC | Wambeke David J. | Chief Business Off | P - Purchase | $2.01 | +33.3K | 200.0K | +20% | +$67.0K |
| D | 2026-09-08 08:31 | 2026-08-28 | NMTC | Wambeke David J. | Chief Business Off | A - Grant | $0.00 | +35.0K | 35.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-27 | P | A | 33,333 | $2.01 | 199,999 | D | — | — | (F1) The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $2.00 and $2.017 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| 2 | Derivative | Option to Purchase Common Stock | 2026-08-28 | A | A | 35,000 | $0.00 | 35,000 | D | $1.77 · — to 2036-08-27 | 35,000 Common Stock | (F2) 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments. |